Shanghai Hengrui Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 2001-12-04
- Employees
- -
- Market Cap
- -
- Website
- http://www.shhrp.com
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 52
- Registration Number
- NCT04772365
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Changsha, China
© Copyright 2025. All Rights Reserved by MedPath